Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
6.93 million HYPE tokens worth approximately $415 million will be unstaked within 7 days, with July 30th being one of the highest single-day amounts in Hyperliquid’s history.

6.93 million HYPE tokens worth approximately $415 million will be unstaked within 7 days, with July 30th being one of the highest single-day amounts in Hyperliquid’s history.

Odaily星球日报Odaily星球日报2026/07/27 11:36
Show original
According to Odaily, monitoring by Onchain Lens shows that in the next 7 days, approximately 6.93 million HYPE tokens are expected to be unstaked from Hyperliquid, valued at around $415 million. Of these, about 3.3 million HYPE tokens (worth approximately $198 million) are expected to be unstaked on July 30, marking one of the largest single-day unstaking events in Hyperliquid’s history.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

U.S. Stocks Movement | Storage Chip Concept Stocks Rise Across the Board, SNDK (SanDisk) Up 6%

On Monday, storage chip concept stocks generally rose, with SanDisk (SNDK.US) up by 6%.

智通财经2026/08/17 13:51
U.S. Stocks Movement | Storage Chip Concept Stocks Rise Across the Board, SNDK (SanDisk) Up 6%

AstraZeneca (AZN.US) / Daiichi Sankyo ADC first-line lung cancer phase III study succeeds

On August 17, AstraZeneca (AZN.US) and Daiichi Sankyo jointly announced that the Phase III DESTINY-Lung04 study of Enhertu (trastuzumab deruxtecan) as a monotherapy for first-line treatment of non-small cell lung cancer (NSCLC) has achieved highly positive results.

智通财经2026/08/17 12:56
AstraZeneca (AZN.US) / Daiichi Sankyo ADC first-line lung cancer phase III study succeeds